We are live on ! Find out more
EXOZ

eXoZymes Inc
EXOZ

9 hedge funds and large institutions have $727K invested in eXoZymes Inc in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

50% more funds holding

Funds holding: 6 → 9 (+3)

0.04% less ownership

Funds ownership: 0.94% → 0.9% (-0.04%)

9% less capital invested

Capital invested by funds: $802K → $727K (-$74.8K)

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$221K
2
UBS Group
UBS Group
Switzerland
+$59.2K
3
Raymond James Financial
Raymond James Financial
Florida
+$24.4K
4
Morgan Stanley
Morgan Stanley
New York
+$15.2K
5
BlackRock
BlackRock
New York
+$4.48K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$332K
2
TRCT
Tower Research Capital (TRC)
New York
-$9.62K

EXOZ Hedge Fund Activity: Q2 2025 in Review

9 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q2 2025, worth a combined $727K — down 9.3% from $802K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EXOZ positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $221K. The largest seller was Vanguard Group, cutting an estimated $332K.

  • 9 institutional investors held eXoZymes Inc (EXOZ) as of Q2 2025, up from 6 in Q1 2025.
  • Funds reported $727K of eXoZymes Inc stock for Q2 2025, down 9.3% quarter-over-quarter.
  • 3 funds opened new eXoZymes Inc positions in Q2 2025 and 0 closed out, a net change of +3 holders.
  • The largest eXoZymes Inc buyer in Q2 2025 was Citadel Advisors, an estimated $221K added.
  • The largest eXoZymes Inc seller in Q2 2025 was Vanguard Group, an estimated $332K sold.

Based on aggregated 13F filings for Q2 2025.